nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetaminophen—SLC22A6—Cyclosporine—focal segmental glomerulosclerosis	0.212	0.308	CbGbCtD
Acetaminophen—CYP2C8—Cyclosporine—focal segmental glomerulosclerosis	0.139	0.203	CbGbCtD
Acetaminophen—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.0972	0.141	CbGbCtD
Acetaminophen—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.0943	0.137	CbGbCtD
Acetaminophen—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.0889	0.129	CbGbCtD
Acetaminophen—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0565	0.0821	CbGbCtD
Acetaminophen—Nephrosis lower nephron—Cyclosporine—focal segmental glomerulosclerosis	0.0335	0.153	CcSEcCtD
Acetaminophen—Breath sounds abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.0183	0.0838	CcSEcCtD
Acetaminophen—UGT1A10—kidney—focal segmental glomerulosclerosis	0.0105	0.164	CbGeAlD
Acetaminophen—Renal tubular necrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00984	0.045	CcSEcCtD
Acetaminophen—Traumatic liver injury—Cyclosporine—focal segmental glomerulosclerosis	0.00944	0.0431	CcSEcCtD
Acetaminophen—Pancreatitis acute—Cyclosporine—focal segmental glomerulosclerosis	0.00761	0.0348	CcSEcCtD
Acetaminophen—SULT1A1—kidney—focal segmental glomerulosclerosis	0.00723	0.113	CbGeAlD
Acetaminophen—PTGS2—nephron—focal segmental glomerulosclerosis	0.007	0.109	CbGeAlD
Acetaminophen—Azotaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0066	0.0302	CcSEcCtD
Acetaminophen—Hypomagnesaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00553	0.0253	CcSEcCtD
Acetaminophen—UGT1A9—kidney—focal segmental glomerulosclerosis	0.00528	0.0825	CbGeAlD
Acetaminophen—Digestion impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00526	0.024	CcSEcCtD
Acetaminophen—SLC22A6—nephron tubule—focal segmental glomerulosclerosis	0.00445	0.0695	CbGeAlD
Acetaminophen—Liver injury—Cyclosporine—focal segmental glomerulosclerosis	0.00418	0.0191	CcSEcCtD
Acetaminophen—Disturbance in attention—Cyclosporine—focal segmental glomerulosclerosis	0.00406	0.0185	CcSEcCtD
Acetaminophen—SLC22A6—cortex of kidney—focal segmental glomerulosclerosis	0.00381	0.0595	CbGeAlD
Acetaminophen—UGT1A1—kidney—focal segmental glomerulosclerosis	0.00362	0.0566	CbGeAlD
Acetaminophen—Hepatocellular injury—Cyclosporine—focal segmental glomerulosclerosis	0.00352	0.0161	CcSEcCtD
Acetaminophen—Eructation—Cyclosporine—focal segmental glomerulosclerosis	0.00345	0.0158	CcSEcCtD
Acetaminophen—PTGS1—endothelium—focal segmental glomerulosclerosis	0.00345	0.0539	CbGeAlD
Acetaminophen—Nightmare—Cyclosporine—focal segmental glomerulosclerosis	0.00339	0.0155	CcSEcCtD
Acetaminophen—PTGS2—endothelium—focal segmental glomerulosclerosis	0.0033	0.0515	CbGeAlD
Acetaminophen—Coma—Cyclosporine—focal segmental glomerulosclerosis	0.00321	0.0147	CcSEcCtD
Acetaminophen—Hepatic function abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00292	0.0133	CcSEcCtD
Acetaminophen—Hepatic failure—Cyclosporine—focal segmental glomerulosclerosis	0.00284	0.013	CcSEcCtD
Acetaminophen—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.00225	0.0103	CcSEcCtD
Acetaminophen—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.00222	0.0101	CcSEcCtD
Acetaminophen—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.00217	0.00992	CcSEcCtD
Acetaminophen—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.00215	0.00982	CcSEcCtD
Acetaminophen—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00211	0.00966	CcSEcCtD
Acetaminophen—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.00206	0.00943	CcSEcCtD
Acetaminophen—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00199	0.00909	CcSEcCtD
Acetaminophen—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.00186	0.0085	CcSEcCtD
Acetaminophen—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.00177	0.00811	CcSEcCtD
Acetaminophen—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00177	0.00807	CcSEcCtD
Acetaminophen—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00177	0.00807	CcSEcCtD
Acetaminophen—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00174	0.00797	CcSEcCtD
Acetaminophen—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00173	0.00793	CcSEcCtD
Acetaminophen—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00173	0.00791	CcSEcCtD
Acetaminophen—CYP2C8—kidney—focal segmental glomerulosclerosis	0.00171	0.0268	CbGeAlD
Acetaminophen—CYP2E1—nephron tubule—focal segmental glomerulosclerosis	0.00164	0.0256	CbGeAlD
Acetaminophen—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.00164	0.00749	CcSEcCtD
Acetaminophen—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.0016	0.00732	CcSEcCtD
Acetaminophen—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00159	0.00727	CcSEcCtD
Acetaminophen—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00158	0.00724	CcSEcCtD
Acetaminophen—CYP1A1—kidney—focal segmental glomerulosclerosis	0.00158	0.0247	CbGeAlD
Acetaminophen—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00155	0.00707	CcSEcCtD
Acetaminophen—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.00154	0.00702	CcSEcCtD
Acetaminophen—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00151	0.00689	CcSEcCtD
Acetaminophen—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00149	0.00682	CcSEcCtD
Acetaminophen—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00148	0.00675	CcSEcCtD
Acetaminophen—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00145	0.00662	CcSEcCtD
Acetaminophen—CYP2E1—kidney—focal segmental glomerulosclerosis	0.00144	0.0225	CbGeAlD
Acetaminophen—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00144	0.00658	CcSEcCtD
Acetaminophen—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00143	0.00652	CcSEcCtD
Acetaminophen—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00142	0.00649	CcSEcCtD
Acetaminophen—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00141	0.00645	CcSEcCtD
Acetaminophen—CYP2E1—cortex of kidney—focal segmental glomerulosclerosis	0.0014	0.0219	CbGeAlD
Acetaminophen—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.0014	0.00642	CcSEcCtD
Acetaminophen—PTGS1—kidney—focal segmental glomerulosclerosis	0.00139	0.0217	CbGeAlD
Acetaminophen—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00139	0.00633	CcSEcCtD
Acetaminophen—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00138	0.00629	CcSEcCtD
Acetaminophen—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00134	0.00613	CcSEcCtD
Acetaminophen—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00133	0.00609	CcSEcCtD
Acetaminophen—PTGS2—kidney—focal segmental glomerulosclerosis	0.00133	0.0207	CbGeAlD
Acetaminophen—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00133	0.00606	CcSEcCtD
Acetaminophen—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00131	0.00598	CcSEcCtD
Acetaminophen—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.0013	0.00596	CcSEcCtD
Acetaminophen—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.0013	0.00594	CcSEcCtD
Acetaminophen—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00129	0.00591	CcSEcCtD
Acetaminophen—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00128	0.00585	CcSEcCtD
Acetaminophen—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00126	0.00578	CcSEcCtD
Acetaminophen—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00125	0.00573	CcSEcCtD
Acetaminophen—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00125	0.00573	CcSEcCtD
Acetaminophen—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00123	0.00562	CcSEcCtD
Acetaminophen—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00123	0.00561	CcSEcCtD
Acetaminophen—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00122	0.00557	CcSEcCtD
Acetaminophen—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00121	0.00554	CcSEcCtD
Acetaminophen—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.0012	0.00546	CcSEcCtD
Acetaminophen—CYP3A4—kidney—focal segmental glomerulosclerosis	0.00116	0.0181	CbGeAlD
Acetaminophen—CYP2D6—kidney—focal segmental glomerulosclerosis	0.00114	0.0178	CbGeAlD
Acetaminophen—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00113	0.00518	CcSEcCtD
Acetaminophen—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00112	0.00511	CcSEcCtD
Acetaminophen—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00112	0.0051	CcSEcCtD
Acetaminophen—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.0011	0.00505	CcSEcCtD
Acetaminophen—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00109	0.00498	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.00495	CcSEcCtD
Acetaminophen—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.00494	CcSEcCtD
Acetaminophen—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00107	0.0049	CcSEcCtD
Acetaminophen—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.00472	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.00469	CcSEcCtD
Acetaminophen—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000996	0.00455	CcSEcCtD
Acetaminophen—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000992	0.00453	CcSEcCtD
Acetaminophen—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000992	0.00453	CcSEcCtD
Acetaminophen—ABCB1—nephron tubule—focal segmental glomerulosclerosis	0.000935	0.0146	CbGeAlD
Acetaminophen—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000924	0.00422	CcSEcCtD
Acetaminophen—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.0009	0.00411	CcSEcCtD
Acetaminophen—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000887	0.00406	CcSEcCtD
Acetaminophen—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000858	0.00392	CcSEcCtD
Acetaminophen—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000829	0.00379	CcSEcCtD
Acetaminophen—ABCB1—kidney—focal segmental glomerulosclerosis	0.000822	0.0128	CbGeAlD
Acetaminophen—ABCB1—cortex of kidney—focal segmental glomerulosclerosis	0.0008	0.0125	CbGeAlD
Acetaminophen—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000798	0.00364	CcSEcCtD
Acetaminophen—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000791	0.00361	CcSEcCtD
Acetaminophen—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00079	0.00361	CcSEcCtD
Acetaminophen—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000786	0.00359	CcSEcCtD
Acetaminophen—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000745	0.0034	CcSEcCtD
Acetaminophen—SULT2A1—Corticotropin-releasing hormone—TGFB1—focal segmental glomerulosclerosis	0.000217	0.00741	CbGpPWpGaD
Acetaminophen—UGT1A9—PPARA activates gene expression—CTGF—focal segmental glomerulosclerosis	0.000217	0.00741	CbGpPWpGaD
Acetaminophen—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—focal segmental glomerulosclerosis	0.000212	0.00725	CbGpPWpGaD
Acetaminophen—CNR1—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00021	0.00717	CbGpPWpGaD
Acetaminophen—CNR1—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.000208	0.00711	CbGpPWpGaD
Acetaminophen—TRPV1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.000206	0.00705	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000199	0.00681	CbGpPWpGaD
Acetaminophen—PTGS2—Aryl Hydrocarbon Receptor—LPL—focal segmental glomerulosclerosis	0.000195	0.00668	CbGpPWpGaD
Acetaminophen—CYP2D6—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	0.000194	0.00665	CbGpPWpGaD
Acetaminophen—CYP2E1—Vitamin A and Carotenoid Metabolism—LPL—focal segmental glomerulosclerosis	0.000194	0.00663	CbGpPWpGaD
Acetaminophen—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—focal segmental glomerulosclerosis	0.00019	0.00649	CbGpPWpGaD
Acetaminophen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—focal segmental glomerulosclerosis	0.000186	0.00636	CbGpPWpGaD
Acetaminophen—CNR1—G alpha (i) signalling events—AGT—focal segmental glomerulosclerosis	0.000186	0.00635	CbGpPWpGaD
Acetaminophen—CNR1—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.000178	0.00608	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000175	0.006	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.000174	0.00595	CbGpPWpGaD
Acetaminophen—CYP1A1—Aryl Hydrocarbon Receptor—LPL—focal segmental glomerulosclerosis	0.000173	0.00593	CbGpPWpGaD
Acetaminophen—CYP1A2—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	0.000165	0.00563	CbGpPWpGaD
Acetaminophen—CNR1—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00016	0.00546	CbGpPWpGaD
Acetaminophen—CNR1—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.000148	0.00505	CbGpPWpGaD
Acetaminophen—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—focal segmental glomerulosclerosis	0.000146	0.005	CbGpPWpGaD
Acetaminophen—CNR1—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.000135	0.00463	CbGpPWpGaD
Acetaminophen—UGT1A9—PPARA activates gene expression—AGT—focal segmental glomerulosclerosis	0.000129	0.00439	CbGpPWpGaD
Acetaminophen—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—focal segmental glomerulosclerosis	0.000126	0.0043	CbGpPWpGaD
Acetaminophen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—focal segmental glomerulosclerosis	0.000125	0.00428	CbGpPWpGaD
Acetaminophen—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—focal segmental glomerulosclerosis	0.000125	0.00428	CbGpPWpGaD
Acetaminophen—CYP1A1—PPARA activates gene expression—CTGF—focal segmental glomerulosclerosis	0.000124	0.00426	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.000123	0.00422	CbGpPWpGaD
Acetaminophen—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—focal segmental glomerulosclerosis	0.000122	0.00417	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000122	0.00416	CbGpPWpGaD
Acetaminophen—CNR1—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.000118	0.00404	CbGpPWpGaD
Acetaminophen—CNR1—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.000117	0.00402	CbGpPWpGaD
Acetaminophen—SULT1E1—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000117	0.004	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.000115	0.00393	CbGpPWpGaD
Acetaminophen—CNR1—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.000112	0.00384	CbGpPWpGaD
Acetaminophen—UGT1A6—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	0.000112	0.00384	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000111	0.00379	CbGpPWpGaD
Acetaminophen—CYP1A2—Aryl Hydrocarbon Receptor—LPL—focal segmental glomerulosclerosis	0.000111	0.00378	CbGpPWpGaD
Acetaminophen—ABCB1—Allograft Rejection—AGTR1—focal segmental glomerulosclerosis	0.000109	0.00373	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000107	0.00367	CbGpPWpGaD
Acetaminophen—ABCB1—HIF-1-alpha transcription factor network—EDN1—focal segmental glomerulosclerosis	0.000107	0.00365	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000107	0.00365	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000104	0.00356	CbGpPWpGaD
Acetaminophen—SULT1A1—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000103	0.00352	CbGpPWpGaD
Acetaminophen—SULT1E1—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000103	0.00352	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000102	0.00349	CbGpPWpGaD
Acetaminophen—CNR1—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	9.87e-05	0.00338	CbGpPWpGaD
Acetaminophen—PTGS1—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	9.63e-05	0.00329	CbGpPWpGaD
Acetaminophen—PTGS1—Selenium Micronutrient Network—ALB—focal segmental glomerulosclerosis	9.61e-05	0.00329	CbGpPWpGaD
Acetaminophen—SULT1E1—Metabolism—GNAQ—focal segmental glomerulosclerosis	9.49e-05	0.00325	CbGpPWpGaD
Acetaminophen—ABCB1—Allograft Rejection—CD40LG—focal segmental glomerulosclerosis	9.15e-05	0.00313	CbGpPWpGaD
Acetaminophen—SULT1A1—Metabolism—CTGF—focal segmental glomerulosclerosis	9.07e-05	0.0031	CbGpPWpGaD
Acetaminophen—CNR1—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	9.03e-05	0.00309	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	8.97e-05	0.00307	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—LIPC—focal segmental glomerulosclerosis	8.87e-05	0.00303	CbGpPWpGaD
Acetaminophen—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—focal segmental glomerulosclerosis	8.67e-05	0.00296	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	8.62e-05	0.00295	CbGpPWpGaD
Acetaminophen—TRPV1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	8.51e-05	0.00291	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—LIPC—focal segmental glomerulosclerosis	8.46e-05	0.00289	CbGpPWpGaD
Acetaminophen—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—focal segmental glomerulosclerosis	8.39e-05	0.00287	CbGpPWpGaD
Acetaminophen—SULT1A1—Metabolism—GNAQ—focal segmental glomerulosclerosis	8.36e-05	0.00286	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	8.2e-05	0.0028	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	8.15e-05	0.00279	CbGpPWpGaD
Acetaminophen—ABCB1—HIF-1-alpha transcription factor network—NOS2—focal segmental glomerulosclerosis	8.1e-05	0.00277	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	7.98e-05	0.00273	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—LIPC—focal segmental glomerulosclerosis	7.96e-05	0.00272	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—CTGF—focal segmental glomerulosclerosis	7.81e-05	0.00267	CbGpPWpGaD
Acetaminophen—CNR1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	7.66e-05	0.00262	CbGpPWpGaD
Acetaminophen—PTGS2—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	7.64e-05	0.00261	CbGpPWpGaD
Acetaminophen—PTGS2—Selenium Micronutrient Network—ALB—focal segmental glomerulosclerosis	7.63e-05	0.00261	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—CTGF—focal segmental glomerulosclerosis	7.45e-05	0.00255	CbGpPWpGaD
Acetaminophen—CYP1A1—PPARA activates gene expression—AGT—focal segmental glomerulosclerosis	7.38e-05	0.00252	CbGpPWpGaD
Acetaminophen—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—focal segmental glomerulosclerosis	7.22e-05	0.00247	CbGpPWpGaD
Acetaminophen—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—focal segmental glomerulosclerosis	7.2e-05	0.00246	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—GNAQ—focal segmental glomerulosclerosis	7.19e-05	0.00246	CbGpPWpGaD
Acetaminophen—PTGS2—Spinal Cord Injury—NOS2—focal segmental glomerulosclerosis	7.18e-05	0.00245	CbGpPWpGaD
Acetaminophen—SULT1E1—Metabolism—LPL—focal segmental glomerulosclerosis	7.14e-05	0.00244	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—CTGF—focal segmental glomerulosclerosis	7e-05	0.00239	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	6.95e-05	0.00238	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—GNAQ—focal segmental glomerulosclerosis	6.86e-05	0.00235	CbGpPWpGaD
Acetaminophen—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	6.82e-05	0.00233	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—LIPC—focal segmental glomerulosclerosis	6.64e-05	0.00227	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	6.61e-05	0.00226	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—GNAQ—focal segmental glomerulosclerosis	6.45e-05	0.00221	CbGpPWpGaD
Acetaminophen—CNR1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	6.35e-05	0.00217	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	6.34e-05	0.00217	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	6.3e-05	0.00215	CbGpPWpGaD
Acetaminophen—SULT1A1—Metabolism—LPL—focal segmental glomerulosclerosis	6.29e-05	0.00215	CbGpPWpGaD
Acetaminophen—SLC22A6—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	6.14e-05	0.0021	CbGpPWpGaD
Acetaminophen—SULT1E1—Metabolism—AGT—focal segmental glomerulosclerosis	6.11e-05	0.00209	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—CTGF—focal segmental glomerulosclerosis	5.85e-05	0.002	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	5.82e-05	0.00199	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	5.81e-05	0.00199	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	5.77e-05	0.00197	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—LPL—focal segmental glomerulosclerosis	5.41e-05	0.00185	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	5.39e-05	0.00184	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—GNAQ—focal segmental glomerulosclerosis	5.39e-05	0.00184	CbGpPWpGaD
Acetaminophen—SULT1A1—Metabolism—AGT—focal segmental glomerulosclerosis	5.38e-05	0.00184	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	5.3e-05	0.00181	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—LPL—focal segmental glomerulosclerosis	5.16e-05	0.00177	CbGpPWpGaD
Acetaminophen—SLC22A6—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	4.99e-05	0.00171	CbGpPWpGaD
Acetaminophen—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—focal segmental glomerulosclerosis	4.98e-05	0.0017	CbGpPWpGaD
Acetaminophen—UGT1A1—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	4.97e-05	0.0017	CbGpPWpGaD
Acetaminophen—UGT1A9—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	4.97e-05	0.0017	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—LPL—focal segmental glomerulosclerosis	4.85e-05	0.00166	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	4.84e-05	0.00166	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	4.74e-05	0.00162	CbGpPWpGaD
Acetaminophen—SULT1E1—Metabolism—ALB—focal segmental glomerulosclerosis	4.69e-05	0.0016	CbGpPWpGaD
Acetaminophen—PTGS2—Spinal Cord Injury—MMP9—focal segmental glomerulosclerosis	4.63e-05	0.00158	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—AGT—focal segmental glomerulosclerosis	4.63e-05	0.00158	CbGpPWpGaD
Acetaminophen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—focal segmental glomerulosclerosis	4.59e-05	0.00157	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—AGT—focal segmental glomerulosclerosis	4.42e-05	0.00151	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	4.28e-05	0.00146	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—AGT—focal segmental glomerulosclerosis	4.15e-05	0.00142	CbGpPWpGaD
Acetaminophen—SULT1A1—Metabolism—ALB—focal segmental glomerulosclerosis	4.13e-05	0.00141	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	4.12e-05	0.00141	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	4.11e-05	0.0014	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—LPL—focal segmental glomerulosclerosis	4.05e-05	0.00139	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	4.03e-05	0.00138	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.98e-05	0.00136	CbGpPWpGaD
Acetaminophen—CYP2A6—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	3.83e-05	0.00131	CbGpPWpGaD
Acetaminophen—PTGS2—Spinal Cord Injury—TGFB1—focal segmental glomerulosclerosis	3.82e-05	0.00131	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	3.8e-05	0.0013	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.77e-05	0.00129	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	3.77e-05	0.00129	CbGpPWpGaD
Acetaminophen—ABCB1—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	3.73e-05	0.00128	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—ALB—focal segmental glomerulosclerosis	3.55e-05	0.00122	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	3.48e-05	0.00119	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—AGT—focal segmental glomerulosclerosis	3.47e-05	0.00119	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	3.45e-05	0.00118	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.41e-05	0.00117	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—ALB—focal segmental glomerulosclerosis	3.39e-05	0.00116	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	3.34e-05	0.00114	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	3.29e-05	0.00112	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—ALB—focal segmental glomerulosclerosis	3.19e-05	0.00109	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.15e-05	0.00108	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	3.06e-05	0.00105	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—LIPC—focal segmental glomerulosclerosis	2.94e-05	0.00101	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—LIPC—focal segmental glomerulosclerosis	2.94e-05	0.00101	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	2.83e-05	0.000969	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.81e-05	0.000962	CbGpPWpGaD
Acetaminophen—ABCB1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	2.8e-05	0.000957	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—ALB—focal segmental glomerulosclerosis	2.66e-05	0.00091	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	2.65e-05	0.000906	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.62e-05	0.000896	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.61e-05	0.000893	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	2.6e-05	0.000888	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—CTGF—focal segmental glomerulosclerosis	2.59e-05	0.000886	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—CTGF—focal segmental glomerulosclerosis	2.59e-05	0.000886	CbGpPWpGaD
Acetaminophen—SLC22A6—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	2.54e-05	0.000867	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	2.49e-05	0.000853	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	2.42e-05	0.000828	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—LIPC—focal segmental glomerulosclerosis	2.4e-05	0.000821	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.39e-05	0.000817	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.39e-05	0.000817	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.32e-05	0.000792	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—LIPC—focal segmental glomerulosclerosis	2.27e-05	0.000776	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.23e-05	0.000764	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	2.16e-05	0.000738	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	2.13e-05	0.000729	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.12e-05	0.000726	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—CTGF—focal segmental glomerulosclerosis	2.11e-05	0.000723	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.01e-05	0.000686	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—CTGF—focal segmental glomerulosclerosis	2e-05	0.000683	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.98e-05	0.000678	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.95e-05	0.000666	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—LIPC—focal segmental glomerulosclerosis	1.91e-05	0.000652	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.84e-05	0.00063	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	1.84e-05	0.000629	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.82e-05	0.000621	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—LPL—focal segmental glomerulosclerosis	1.8e-05	0.000614	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—LPL—focal segmental glomerulosclerosis	1.8e-05	0.000614	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—LIPC—focal segmental glomerulosclerosis	1.79e-05	0.000613	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	1.73e-05	0.000591	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.71e-05	0.000586	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—LIPC—focal segmental glomerulosclerosis	1.69e-05	0.000578	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—CTGF—focal segmental glomerulosclerosis	1.68e-05	0.000574	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.65e-05	0.000566	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—CTGF—focal segmental glomerulosclerosis	1.58e-05	0.00054	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—LIPC—focal segmental glomerulosclerosis	1.55e-05	0.00053	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.55e-05	0.000528	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—AGT—focal segmental glomerulosclerosis	1.54e-05	0.000526	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—AGT—focal segmental glomerulosclerosis	1.54e-05	0.000526	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.52e-05	0.00052	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—CTGF—focal segmental glomerulosclerosis	1.49e-05	0.000509	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.48e-05	0.000506	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	1.48e-05	0.000505	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—LPL—focal segmental glomerulosclerosis	1.46e-05	0.000501	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.45e-05	0.000497	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.39e-05	0.000477	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—LPL—focal segmental glomerulosclerosis	1.39e-05	0.000475	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—LPL—focal segmental glomerulosclerosis	1.39e-05	0.000474	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.37e-05	0.000469	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—CTGF—focal segmental glomerulosclerosis	1.36e-05	0.000467	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	1.35e-05	0.000462	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—LIPC—focal segmental glomerulosclerosis	1.27e-05	0.000435	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.26e-05	0.000432	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—LIPC—focal segmental glomerulosclerosis	1.26e-05	0.000431	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.26e-05	0.00043	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—AGT—focal segmental glomerulosclerosis	1.25e-05	0.000428	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	1.19e-05	0.000407	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—AGT—focal segmental glomerulosclerosis	1.18e-05	0.000405	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—ALB—focal segmental glomerulosclerosis	1.18e-05	0.000403	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—ALB—focal segmental glomerulosclerosis	1.18e-05	0.000403	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—LPL—focal segmental glomerulosclerosis	1.16e-05	0.000398	CbGpPWpGaD
Acetaminophen—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	1.16e-05	0.000395	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.14e-05	0.000388	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—CTGF—focal segmental glomerulosclerosis	1.12e-05	0.000383	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—CTGF—focal segmental glomerulosclerosis	1.11e-05	0.00038	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.1e-05	0.000375	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—LPL—focal segmental glomerulosclerosis	1.09e-05	0.000374	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—NOS2—focal segmental glomerulosclerosis	1.08e-05	0.000371	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—LIPC—focal segmental glomerulosclerosis	1.08e-05	0.000369	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.03e-05	0.000353	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—LPL—focal segmental glomerulosclerosis	1.03e-05	0.000353	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.02e-05	0.00035	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—AGT—focal segmental glomerulosclerosis	9.95e-06	0.00034	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	9.7e-06	0.000332	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—ALB—focal segmental glomerulosclerosis	9.62e-06	0.000329	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—CTGF—focal segmental glomerulosclerosis	9.49e-06	0.000325	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—LPL—focal segmental glomerulosclerosis	9.46e-06	0.000324	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—AGT—focal segmental glomerulosclerosis	9.36e-06	0.00032	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—SERPINE1—focal segmental glomerulosclerosis	9.13e-06	0.000312	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—ALB—focal segmental glomerulosclerosis	9.09e-06	0.000311	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—AGT—focal segmental glomerulosclerosis	8.83e-06	0.000302	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—GNAQ—focal segmental glomerulosclerosis	8.75e-06	0.000299	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	8.32e-06	0.000285	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	8.24e-06	0.000282	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—AGT—focal segmental glomerulosclerosis	8.09e-06	0.000277	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—LPL—focal segmental glomerulosclerosis	7.77e-06	0.000266	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—LPL—focal segmental glomerulosclerosis	7.7e-06	0.000263	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—ALB—focal segmental glomerulosclerosis	7.63e-06	0.000261	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	7.33e-06	0.000251	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—ALB—focal segmental glomerulosclerosis	7.19e-06	0.000246	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	7.05e-06	0.000241	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—ALB—focal segmental glomerulosclerosis	6.77e-06	0.000232	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	6.75e-06	0.000231	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—AGT—focal segmental glomerulosclerosis	6.64e-06	0.000227	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—AGT—focal segmental glomerulosclerosis	6.59e-06	0.000225	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—LPL—focal segmental glomerulosclerosis	6.58e-06	0.000225	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—ALB—focal segmental glomerulosclerosis	6.21e-06	0.000212	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—TGFB1—focal segmental glomerulosclerosis	5.77e-06	0.000197	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—AGT—focal segmental glomerulosclerosis	5.63e-06	0.000192	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	5.41e-06	0.000185	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—ALB—focal segmental glomerulosclerosis	5.1e-06	0.000174	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	5.08e-06	0.000174	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—ALB—focal segmental glomerulosclerosis	5.05e-06	0.000173	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	4.34e-06	0.000149	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—ALB—focal segmental glomerulosclerosis	4.32e-06	0.000148	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	3.33e-06	0.000114	CbGpPWpGaD
